Now showing items 1-1 of 1

    • Evaluation of a novel antibody to define histone 3.3 G34R mutant brain tumours. 

      Haque, F; Varlet, P; Puntonet, J; Storer, L; Bountali, A; Rahman, R; Grill, J; Carcaboso, AM; Jones, C; Layfield, R; Grundy, RG (2017-06-06)
      Missense somatic mutations affecting histone H3.1 and H3.3 proteins are now accepted as the hallmark of paediatric diffuse intrinsic pontine gliomas (DIPG), non-brain stem paediatric high grade gliomas (pHGG) as well as a ...